0001104659-21-025193.txt : 20210218 0001104659-21-025193.hdr.sgml : 20210218 20210218160113 ACCESSION NUMBER: 0001104659-21-025193 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210217 FILED AS OF DATE: 20210218 DATE AS OF CHANGE: 20210218 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40030 FILM NUMBER: 21649439 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 BUSINESS PHONE: 9148477000 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 FORMER NAME: FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930328 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Decibel Therapeutics, Inc. CENTRAL INDEX KEY: 0001656536 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 464198709 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1325 BOYLSTON STREET STREET 2: SUITE 500 CITY: BOSTON STATE: MA ZIP: 02215 BUSINESS PHONE: 617-370-8701 MAIL ADDRESS: STREET 1: 1325 BOYLSTON STREET STREET 2: SUITE 500 CITY: BOSTON STATE: MA ZIP: 02215 4 1 tm216952-1_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2021-02-17 1 0001656536 Decibel Therapeutics, Inc. DBTX 0000872589 REGENERON PHARMACEUTICALS, INC. REGENERON PHARMACEUTICALS, INC. 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 0 0 1 0 Common Stock 2021-02-17 4 C 0 2097314 A 2097314 D Series B Preferred Stock 2021-02-17 4 C 0 12500000 0 D Common Stock 989299 0 D Series C Preferred Stock 2021-02-17 4 C 0 14000000 0 D Common Stock 1108015 0 D 1. The Series B Preferred Stock and Series C Preferred Stock converted into shares of common stock of Decibel Therapeutics, Inc. ("Decibel") on an approximately one-for-0.079 basis upon the closing of Decibel's initial public offering, which occurred on February 17, 2021. The Series B Preferred Stock and Series C Preferred Stock had no expiration date. The reported number of shares of underlying common stock and the conversion ratio give effect to Decibel's one-for-5.3 reverse stock split, which became effective on February 5, 2021. /s/ Richard Gluckselig, Executive Director, Assistant General Counsel and Assistant Secretary 2021-02-18